HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antisense Oligonucleotide Rescue of Deep-Intronic Variants Activating Pseudoexons in the 6-Pyruvoyl-Tetrahydropterin Synthase Gene.

Abstract
We report two new 6-pyruvoyl-tetrahydropterin synthase splicing variants identified through genomic sequencing and transcript analysis in a patient with tetrahydrobiopterin deficiency, presenting with hyperphenylalaninemia and monoamine neurotransmitter deficiency. Variant c.243 + 3A>G causes exon 4 skipping. The deep-intronic c.164-672C>T variant creates a potential 5' splice site that leads to the inclusion of four overlapping pseudoexons, corresponding to exonizations of an antisense short interspersed nuclear element AluSq repeat sequence. Two of the identified pseudoexons have been reported previously, activated by different deep-intronic variants, and were also detected at residual levels in control cells. Interestingly, the predominant pseudoexon is nearly identical to a disease causing activated pseudoexon in the F8 gene, with the same 3' and 5' splice sites. Splice switching antisense oligonucleotides (SSOs) were designed to hybridize with splice sites and/or predicted binding sites for regulatory splice factors. Different SSOs corrected the aberrant pseudoexon inclusion, both in minigenes and in fibroblasts from patients carrying the new variant c.164-672C>T or the previously described c.164-716A>T. With SSO treatment PTPS protein was recovered, illustrating the therapeutic potential of the approach, for patients with different pseudoexon activating variants in the region. In addition, the natural presence of pseudoexons in the wild type context suggests the possibility of applying the antisense strategy in patients with hypomorphic PTS variants with the purpose of upregulating their expression to increase overall protein and activity.
AuthorsAinhoa Martínez-Pizarro, Fátima Leal, Lise Lolle Holm, Thomas K Doktor, Ulrika S S Petersen, María Bueno, Beat Thöny, Belén Pérez, Brage S Andresen, Lourdes R Desviat
JournalNucleic acid therapeutics (Nucleic Acid Ther) Vol. 32 Issue 5 Pg. 378-390 (10 2022) ISSN: 2159-3345 [Electronic] United States
PMID35833796 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 6-pyruvoyltetrahydropterin synthase
  • RNA Splice Sites
  • Oligonucleotides, Antisense
  • Phosphorus-Oxygen Lyases
  • Oligonucleotides
Topics
  • Humans
  • RNA Splice Sites (genetics)
  • Oligonucleotides, Antisense (genetics, therapeutic use)
  • Phosphorus-Oxygen Lyases (genetics)
  • Exons (genetics)
  • Introns (genetics)
  • RNA Splicing (genetics)
  • Mutation
  • Oligonucleotides

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: